Despite being a significant human health problem, a majority of KSHV studies have been restricted to the overexpression system of the selected viral genes in the absence of viral complete genome and Infection, leading to limited understanding to in vivo KSHV persistence and pathogenesis that are essential in developing safe and effective anti-viral agents and vaccines against this oncogenic pathogen. Specifically, understanding how KSHV gene products contribute to the establishment of persistent infection and pathogenesis requires a reverse genetics approach for the viral genetic deficiencies, an in vitro and in vivo assay system for the viral oncogenesis, and an animal model for the in vivo viral persistence under active host immune conditions. Fortunately, our Program Project Grant (PPG) leaders have recently established a new """"""""infectious"""""""" bacterial artificial clone (BACI6) of KSHV genome that significantly improves the efficiency of the genetic manipulation and virus production (Project 1), a novel system to investigate host's control of the KSHV nucleotide metabolism (Project 2), an efficient KSHV infection and transformation system using primary embryonic metanephric mesenchymal stem cells (MSC cells) (Project 3), and a well-controlled in vivo infection system using a humanized mouse model where KSHV establishes persistent infection and is disseminated into the B and monocyte lineages (Core). Thusly, this multi-disciplinary PPG application is directed toward investigating the host's tricks of Immune recognition and attack as well as the KSHV's tactics of immune evasion and pathogenesis by utilizing recently developed """"""""infectious"""""""" KSHV genetic system, in vitro and in vivo transformation assays, and in vivo humanized mouse models. The major goal of this multi-project grant application is to address (1) how hosts have developed effective mechanisms necessary to control KSHV infection and replication, (2) how KSHV has evolved the various mechanisms necessary to thwart and exploit the host defenses, and (3) how KSHV has conferred the infected cells with oncogenic signatures. This application consists of three Projects with multidisciplinary focused schemes. In addition, the Cores provide an efficient genetic manipulation system for KSHV mutagenesis, a state-of-art humanized mouse model for KSHV persistence and a MSC cell/nude mouse system for KSHV oncogenesis and the Administrative Core provides the overall program milestone and data dissemination.

Public Health Relevance

In order to improve our capability of responding to this emerging cancer in immunosuppressed patients more quickly and effectively, we will improve our understanding of how hosts and KSHV combat each other and how KSHV persists in the immune compromised hosts.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA180779-01
Application #
8603056
Study Section
Special Emphasis Panel (ZCA1-RPRB-J (M1))
Program Officer
Read-Connole, Elizabeth Lee
Project Start
2013-08-13
Project End
2018-07-31
Budget Start
2013-08-13
Budget End
2014-07-31
Support Year
1
Fiscal Year
2013
Total Cost
$1,463,663
Indirect Cost
$571,412
Name
University of Southern California
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Liang, Qiming; Wei, Dahai; Chung, Brian et al. (2018) Novel Role of vBcl2 in the Virion Assembly of Kaposi's Sarcoma-Associated Herpesvirus. J Virol 92:
Foo, Suan-Sin; Chen, Weiqiang; Chan, Yen et al. (2018) Biomarkers and immunoprofiles associated with fetal abnormalities of ZIKV-positive pregnancies. JCI Insight 3:
Zhang, Junjie; Zhao, Jun; Xu, Simin et al. (2018) Species-Specific Deamidation of cGAS by Herpes Simplex Virus UL37 Protein Facilitates Viral Replication. Cell Host Microbe 24:234-248.e5
Foo, Suan-Sin; Chen, Weiqiang; Chan, Yen et al. (2017) Asian Zika virus strains target CD14+ blood monocytes and induce M2-skewed immunosuppression during pregnancy. Nat Microbiol 2:1558-1570
Yuan, Hongfeng; Tan, Brandon; Gao, Shou-Jiang (2017) Tenovin-6 impairs autophagy by inhibiting autophagic flux. Cell Death Dis 8:e2608
Hwang, Sung-Woo; Kim, DongIk; Jung, Jae U et al. (2017) KSHV-encoded viral interferon regulatory factor 4 (vIRF4) interacts with IRF7 and inhibits interferon alpha production. Biochem Biophys Res Commun 486:700-705
Yuan, Hongfeng; He, Meilan; Cheng, Fan et al. (2017) Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy. Oncotarget 8:14912-14924
Zhu, Ying; Li, Tingting; Ramos da Silva, Suzane et al. (2017) A Critical Role of Glutamine and Asparagine ?-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus. MBio 8:
Cheng, Fan; He, Meilan; Jung, Jae U et al. (2016) Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase. J Virol 90:6515-6525
Li, Wan; Yan, Qin; Ding, Xiangya et al. (2016) The SH3BGR/STAT3 Pathway Regulates Cell Migration and Angiogenesis Induced by a Gammaherpesvirus MicroRNA. PLoS Pathog 12:e1005605

Showing the most recent 10 out of 67 publications